Synmosa Biopharma (ROCO:4114) Days Sales Outstanding : 72.76 (As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma Days Sales Outstanding?

Synmosa Biopharma's average Accounts Receivable for the three months ended in Mar. 2025 was NT$1,154 Mil. Synmosa Biopharma's Revenue for the three months ended in Mar. 2025 was NT$1,448 Mil. Hence, Synmosa Biopharma's Days Sales Outstanding for the three months ended in Mar. 2025 was 72.76.

The historical rank and industry rank for Synmosa Biopharma's Days Sales Outstanding or its related term are showing as below:

ROCO:4114' s Days Sales Outstanding Range Over the Past 10 Years
Min: 70.28 Med: 75.63 Max: 92.56
Current: 70.28

During the past 13 years, Synmosa Biopharma's highest Days Sales Outstanding was 92.56. The lowest was 70.28. And the median was 75.63.

ROCO:4114's Days Sales Outstanding is ranked better than
52.92% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.225 vs ROCO:4114: 70.28

Synmosa Biopharma's Days Sales Outstanding declined from Mar. 2024 (73.63) to Mar. 2025 (72.76).

Synmosa Biopharma Days Sales Outstanding Historical Data

The historical data trend for Synmosa Biopharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synmosa Biopharma Days Sales Outstanding Chart

Synmosa Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

74.88

75.63

70.91

71.74

71.73

Synmosa Biopharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															73.63	71.55	68.90	68.26	72.76

Competitive Comparison of Synmosa Biopharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Synmosa Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synmosa Biopharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synmosa Biopharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Synmosa Biopharma's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Synmosa Biopharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Synmosa Biopharma's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (1023.855	+	1157.221)	/	2 )	/	5549.549	*	365
=	1090.538					/	5549.549	*	365
=	71.73

Synmosa Biopharma's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (1157.221	+	1151.151)	/	2 )	/	1447.511	*	365 / 4
=	1154.186					/	1447.511	*	365 / 4
=	72.76

Synmosa Biopharma (ROCO:4114) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Synmosa Biopharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Synmosa Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Synmosa Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN

Website

https://www.synmosa.com.tw

Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products, medical devices, cosmetics, animal drugs, chemical food additives, and beverages. It is also involved in manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. The company provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. The reporting segments of the company are; the Generic Drugs segment which derives key revenue, and the Active Pharmaceutical Ingredients segment.

Synmosa Biopharma Headlines

No Headlines